Cargando…
Tocilizumab: Invasive pulmonary aspergillosis and Escherichia coli infection due to off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644996/ http://dx.doi.org/10.1007/s40278-020-85566-3 |
Ejemplares similares
-
Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021) -
Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021) -
Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021) -
Dexamethasone/tocilizumab: Herpes virus reactivation and COVID-19-associated pulmonary Aspergillosis secondary to off label use: case report
Publicado: (2021) -
Multiple drugs: Invasive pulmonary aspergillosis and Off label use: 4 case reports
Publicado: (2021)